Among the nonvirion proteins of the vaccinia virus (VACV), a 94-kDa long protein is most abundantly present; the protein is a truncated form of the 150-kDa A-type inclusion (ATI) protein of the cowpox virus encoded by the ati gene.
This VACV protein does not form intracellular ATIs, being as it is a major immunogen upon infection/immunization of humans or animals with the VACV.
variants demonstrated that the mutant LIVPΔati elicits a stronger protective response compared to the parent LIVP.
The human HLA-A*0201 Vaccinia virus D1R (VLYNGVNYL) complex protein is a complex of HLA-A*0201 of the MHC Class I, B2M, and VLYNGVNYL peptide of the vaccinia virus.
特徴
Biotinylated Human HLA-A*02:01&B2M&Vaccinia virus (VLYNGVNYL) Complex Protein is produced by co-expression of HLA and B2M loaded with Vaccinia virus peptide.This protein carries a polyhistidine tag at the C-terminus, followed by an Avi tag (Avitag).The protein has a calculated MW of 36.3 kDa and 11.7 kDa.
The protein migrates as 40-43 kDa and 10 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.
仕様
容量：200ug
Source：Biotinylated Human HLA-A*02:01&B2M&Vaccinia virus (VLYNGVNYL) Complex Protein (HLR-H82E5) is expressed from human 293 cells (HEK293). It contains AA Gly 25 - Ile 308 (HLA-A*02:01) & Ile 21 - Met 119 (B2M) & VLYNGVNYL peptide (Accession # AAA59606.1 (HLA-A*02:01) & P61769-1 (B2M) & VLYNGVNYL).
Species Reactivity：Human
Host：HEK293
Tag：C-10×His & C-Avi
Exp Region：Gly 25 - Ile 308 (HLA-A*02:01) & Ile 21 - Met 119 (B2M) & VLYNGVNYL peptide
